Clincosm LogoSign in Get a demo

Myocardial Ischemia

Showing NaN - NaN of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy Trial in Beijing (De-escalated Dual

Recruiting
  • Coronary Artery Disease
  • +6 more
  • De-escalated Dual Antiplatelet Therapy
  • Dual Antiplatelet Therapy
  • Beijing, China
    Fuwai Hospital
Dec 13, 2022

Sensor-equipped Ultrathin Pressure Microcatheter Versus Pressure

Enrolling by invitation
  • Coronary Artery Disease
  • +2 more
  • Randomized physiological measurements by the two systems
  • Beijing, Beijing, China
  • +10 more
Oct 30, 2022

Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome Trial in China (Clopidogrel and Aspirin dual-antiplatelet

Recruiting
  • Coronary Artery Disease
  • +9 more
  • Clopidogrel and Aspirin dual-antiplatelet therapy
  • Aspirin monotherapy
  • Beijing, Beijing, China
  • +108 more
Oct 25, 2022

Stable Chronic Angina, Ischemic Heart Disease, Coronary Artery Disease Trial in Beijing (remote intervention, Routine outpatient

Recruiting
  • Stable Chronic Angina
  • +4 more
  • remote intervention
  • Routine outpatient follow-up
  • Beijing, Beijing, China
    Fuwai Hospital, Chinese Academy of Medical Science; National Cen
Oct 20, 2022

Beijing Hospital Atherosclerosis Study

Recruiting
  • Atherosclerosis
  • +4 more
    • Beijing, Beijing, China
      Bejing Hosptial
    Apr 20, 2022

    Coronary Artery Disease (CAD), Myocardial Ischemia Trial in Beijing (XTR004)

    Completed
    • Coronary Artery Disease (CAD)
    • Myocardial Ischemia
    • XTR004
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 23, 2022

    CFD-based RuiXin-FFR by Comparing With Pressure-wire-based FFR

    Completed
    • Coronary Artery Disease
    • +2 more
    • Pressure wire fractional flow reserve
    • CFD-based RuiXin-FFR
    • Beijing, China
      Shaoping Nie
    Sep 2, 2021

    Ischemic Heart Disease, Myocardial Ischemia, Coronary Disease Trial in Beijing (AVI® Arsenic trioxide drug eluting stent

    Active, not recruiting
    • Ischemic Heart Disease
    • +3 more
    • AVI® Arsenic trioxide drug eluting stent delivery system
    • Firebird2® sirolimus eluting stent system
    • Beijing, Beijing, China
      Peking University First Hospital
    Nov 14, 2019

    Atherosclerotic DEtermiNants of Myocardial IsChEmia

    Completed
    • Myocardial Ischemia
      • Huntsville, Alabama
      • +17 more
      Nov 11, 2019

      The FAVOR II China Study

      Completed
      • Coronary Artery Disease
      • +7 more
      • Fractional Flow Reserve (FFR)
      • Beijing, Beijing, China
      • +4 more
      Jul 25, 2017

      Coronary Occlusion, Thrombosis (Stent Thrombosis), Vascular Disease Trial in Beijing, Shanghai (XIENCE V EECSS, CYPHER SELECT

      Completed
      Has Results
      • Coronary Occlusion
      • +7 more
      • XIENCE V EECSS
      • CYPHER SELECT PLUS SECSS
      • Beijing, China
      • +1 more
      Jul 14, 2016

      Triple-vessel Coronary Artery Disease Underwent Three Different

      Unknown status
      • Coronary Artery Disease
      • +2 more
        • Beijing, Beijing, China
          Fuwai Hospital
        Dec 17, 2015

        Coronary Artery Stenosis, Coronary Arteriosclerosis, Coronary Artery Disease Trial in Worldwide (XIENCE V®/ XIENCE PRIME™)

        Completed
        • Coronary Artery Stenosis
        • +7 more
        • XIENCE V®/ XIENCE PRIME™
        • Buenos Aires, Argentina
        • +94 more
        May 12, 2015

        Acute Coronary Syndrome, Myocardial Infarction, Myocardial Ischemia Trial in Worldwide (Rivaroxaban 2.5 mg, Rivaroxaban 5 mg,

        Completed
        Has Results
        • Acute Coronary Syndrome
        • +3 more
        • Rivaroxaban 2.5 mg
        • +3 more
        • Birmingham, Alabama
        • +583 more
        Aug 26, 2014